Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.30 |
| ▸ | CTSG | P08311 | 1/20 | 0.30 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.30 |
| ▸ | CMA1 | P23946 | 1/20 | 0.30 |
| ▸ | NAAA | Q02083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14938147 | 0.91 | ALDH1A1 (0.46) | ALDH1A1TSHRLMNADGKAPRSS1 | |
| SCHEMBL19863302 | 0.88 | ALDH1A1 (0.43) | ALDH1A1TSHRLMNADGKAPRSS1 | |
| SCHEMBL6887378 | 0.88 | ALDH1A1 (0.43) | ALDH1A1TSHRLMNADGKAPRSS1 | |
| SCHEMBL3173479 | 0.87 | ALDH1A1 (0.71) | ALDH1A1TSHRLMNADGKACYP1A2 | |
| SCHEMBL24246432 | 0.86 | TSHR (0.36) | ALDH1A1TSHRLMNAKDM4EMEN1 | |
| SCHEMBL2789194 | 0.84 | ALDH1A1 (0.50) | ALDH1A1TSHRLMNAKDM4EMEN1 | |
| SCHEMBL2199876 | 0.81 | TSHR (0.41) | ALDH1A1TSHRLMNAKDM4EMEN1 | |
| SCHEMBL6738571 | 0.80 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL25304019 | 0.80 | ALDH1A1 (0.54) | ALDH1A1TSHRLMNADGKA | |
| SCHEMBL21811919 | 0.79 | DGKA (0.41) | ALDH1A1TSHRLMNAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100022415-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KET. (HU) | 2010-01-28 | — | — | US | claimed |
| EP-2080026-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | Avicor Kft. (HU) | 2009-07-22 | — | — | EP | claimed |
| WO-2008023208-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KFT. (HU) | 2008-02-28 | — | — | WO | claimed |
| CN-119505178-B | Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof | 浙江工业大学 | 2025-04-04 | — | — | CN | disclosed |
| CN-119505178-A | Cured product of organic phosphine modified unsaturated resin and polyhalogenated compound and preparation method thereof | 浙江工业大学 | 2025-02-25 | — | — | CN | disclosed |
| CN-102477082-A | Method for synthesizing carbetocin by liquid phase synthesis method | HANGZHOU HEJIN TECHNOLOGY CO LTD | 2012-05-30 | — | — | CN | disclosed |
| US-20100022415-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KET. (HU) | 2010-01-28 | — | — | US | disclosed |
| EP-2080026-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | Avicor Kft. (HU) | 2009-07-22 | — | — | EP | disclosed |
| WO-2008023208-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | AVICOR KFT. (HU) | 2008-02-28 | — | — | WO | disclosed |
| US-5622944-A | MODIFIED 17-HYDROXY STEROL; TRANSDERMAL ELECTROTRANSPORT ENHANCEMENT | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-04-22 | — | — | US | disclosed |
| US-4883876-A | CEREBRAL VASCULAR DISORDERS, ARTERIOSCLEROSIS, STROKE, DEMENTIA | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 1989-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022415-A1 | ACTIVE CARRIER, ITS PRODUCTION AND ITS USE | SLC43A1, PAICS, PIGO | ALDH1A1 1461/4885TSHR 1339/4885LMNA 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.